Literature DB >> 9525811

Effects of DFMO on glioma cell proliferation, migration and invasion in vitro.

A J Terzis1, P H Pedersen, B G Feuerstein, H Arnold, R Bjerkvig, D F Deen.   

Abstract

The polyamine inhibitor DL-alpha-difluoromethylornithine (DFMO) is a specific irreversible inhibitor of ornithine decarboxylase which is a rate-limiting enzyme in the polyamine bio-synthesis pathway. The present study describes the effects of DFMO on glioma cell proliferation, migration and invasion using multicellular spheroids from three glioma cell lines (GaMg, U-251 Mg and U-87 Mg). 10 mM DFMO reduced cell migration in the three cell lines by about 30-50%. 1 mM putrescine, added together with DFMO inhibited the DFMO effect. A stronger effect was observed in the growth assay where 10 mM DFMO reduced the spheroid growth, for all cell lines, by 90%. This effect was also reversed by adding 1 mM of putrescine. In vitro tumor cell invasion experiments indicated after 3 days of confrontation, an extensive invasion also after 10 mM DFMO treatment. The brain aggregate volumes were reduced to about the same extent as in the absence of drug, suggesting essentially no effects of DFMO on the invasive process. It is concluded that the tumor spheroids retained their ability to invade normal brain tissue even after DFMO exposure. However, DFMO inhibited spheroid growth and cell migration which supports the notion that cell growth, migration and invasion are biological properties that are not necessarily related to each other.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525811     DOI: 10.1023/a:1005811403041

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

Review 1.  Polyamines in rapid growth and cancer.

Authors:  J Jänne; H Pösö; A Raina
Journal:  Biochim Biophys Acta       Date:  1978-04-06

2.  Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain.

Authors:  P H Pedersen; K Marienhagen; S Mørk; R Bjerkvig
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

3.  Influence of cells number on directional migration of MO4 cells in vitro.

Authors:  G Storme; M Mareel; G De Bruyne
Journal:  Arch Geschwulstforsch       Date:  1981

4.  Correlation between the effects of polyamine analogues on DNA conformation and cell growth.

Authors:  H S Basu; B G Feuerstein; D F Deen; W P Lubich; R J Bergeron; K Samejima; L J Marton
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

5.  Polyamines and nucleic acids during development of the chick embryo.

Authors:  C M Caldarera; B Barbiroli; G Moruzzi
Journal:  Biochem J       Date:  1965-10       Impact factor: 3.857

6.  Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.

Authors:  M Prados; L Rodriguez; M Chamberlain; P Silver; V Levin
Journal:  Neurosurgery       Date:  1989-06       Impact factor: 4.654

7.  Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.

Authors:  V A Levin; M C Chamberlain; M D Prados; A K Choucair; M S Berger; P Silver; M Seager; P H Gutin; R L Davis; C B Wilson
Journal:  Cancer Treat Rep       Date:  1987-05

8.  Characteristics of human and rat glioma cells grown in a defined medium.

Authors:  L A Akslen; K J Andersen; R Bjerkvig
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

Review 9.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

10.  Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group.

Authors: 
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

View more
  4 in total

1.  Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.

Authors:  George A Alexiou; Konstantinos I Tsamis; Evrysthenis Vartholomatos; Evangelia Peponi; Eftychia Tzima; Ifigeneia Tasiou; Efstathios Lykoudis; Pericles Tsekeris; Athanasios P Kyritsis
Journal:  J Neurooncol       Date:  2015-05-03       Impact factor: 4.130

2.  Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro.

Authors:  Jan Gliemroth; Thomas Feyerabend; Christiane Gerlach; Hans Arnold; A Jorge A Terzis
Journal:  Neurosurg Rev       Date:  2003-02-12       Impact factor: 3.042

3.  Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.

Authors:  Stine S Jensen; Stine A Petterson; Bo Halle; Charlotte Aaberg-Jessen; Bjarne W Kristensen
Journal:  BMC Cancer       Date:  2017-03-07       Impact factor: 4.430

4.  Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.

Authors:  W Günther; E Pawlak; R Damasceno; H Arnold; A J Terzis
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.